Visus Therapeutics

0 followers


Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.

Industries

Headquarters

Stage

Employees

Links

Org chart

Ben Bergo

Collapse
Rhett Schiffman
Chief Medical Officer & Head of R&D
Lisa Simpson
VP, Clinical Operations & Compliance
Andy Firpo
VP, Information Technology
Patrick Hughes
VP, Pharmaceutical Development
Esther Cuno
VP, Human Resources
Robert Boxeth
Senior Quality Assurance Specialist
Kate Bishop
AVP, Legal & Intellectual Property
Dell Larned
Associate Director, Project Management
Dixie-Lee Shurland
Project Manager